Aug 30, 2021 | BALTIMORE – Complete Omics’ Clinical Genomics team announced a collaboration with Professor Ching-shuen Wang from Taipei Medical University on a series of RNA-seq projects leveraging our DEEPER-SeqS clinical genomics assays for biological discoveries from hard-to-sequence clinical samples.
July 18, 2021 | BALTIMORE – Complete Omics’ Clinical Proteomics team announced a collaboration with Dr. Yiping He from Duke University on a series of grants focusing on leveraging our labeling-dependent large scale quantitative proteomics assays for biological discoveries.
July 16th, 2021 | BALTIMORE – Complete Omics’ Clinical Proteomics team announced a collaboration with Prof. Dr. Roland Schüle from University Medical Center Freiburg, the teaching hospital of the University of Freiburg.
July 15, 2021 | BALTIMORE – Complete Omics’ Clinical Proteomics team announced a collaboration with Dr. Benjamin Vincent from The University of North Carolina, on neoantigen-related projects.
July 10, 2021 | BALTIMORE – Complete Omics’ Clinical Proteomics team announced a collaboration with Dr. Christian S. Hinrichs from Rutgers Cancer Institute of New Jersey.
June 25, 2021 | BALTIMORE – Complete Omics’ Clinical Proteomics team announced a collaboration with Arvinas (Nasdaq:ARVN), a pharmaceutical company inventing the famous proprietary PROTAC® protein degraders.
June 20, 2021 | BALTIMORE – Complete Omics’ announced a collaboration with ErVaccine Technologies, a pharmaceutical company headquartered in Lyon, Rhone-Alpes, Francey, on a neoantigen validation and quantification project.
June 16, 2021 | BALTIMORE – Complete Omics’ Clinical Proteomics team announced a collaboration with Dr. Yonghong Wan’s lab at McMaster University at Hamilton Ontario Canada.
June 4, 2021 | BALTIMORE – Complete Omics’ Clinical Proteomics team announced a collaboration with Dr. Sun Shi-yong lab in the Winship Cancer Institute of Emory University.
May 10, 2021 | BALTIMORE – Complete Omics’ Clinical Proteomics team announced a collaboration with Professor Zhenghe Wang and his team from the Case Western Researve University on a series of clinical proteomics projects focusing on leveraging our Complete360 targete detection pipeline for biological discoveries.
Complete Omics — making OMICS-based clinical care a reality.
